Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Return on Equity (2016 - 2026)

Standard Biotools has reported Return on Equity over the past 15 years, most recently at 0.0% for Q4 2025.

  • Quarterly Return on Equity changed 0.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Equity was 0.0% for Q4 2025 at Standard Biotools, up from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.2% in Q2 2022 and troughed at 0.02% in Q1 2022.
  • The 5-year median for Return on Equity is 0.0% (2024), against an average of 0.01%.
  • Year-over-year, Return on Equity rose 21bps in 2022 and then dropped -19bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.01% in 2021, then surged by 622bps to 0.03% in 2022, then crashed by -91bps to 0.0% in 2023, then plummeted by -155bps to 0.0% in 2024, then increased by 29bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for LAB's Return on Equity are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).